🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 15 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/08/1997 | 44,92 | 46,32 | 44,45 | 44,92 | +0,52% | 4,17% | 35.453 |
| 15/08/1997 | 45,85 | 45,85 | 43,51 | 44,68 | -2,05% | 5,10% | 65.456 |
| 14/08/1997 | 45,62 | 46,32 | 44,92 | 45,62 | +0,00% | 3,08% | 29.762 |
| 13/08/1997 | 47,26 | 47,26 | 45,62 | 45,62 | -2,99% | 3,47% | 31.071 |
| 12/08/1997 | 46,55 | 48,66 | 46,55 | 47,02 | +1,01% | 4,52% | 53.754 |
| 11/08/1997 | 46,32 | 46,79 | 46,32 | 46,55 | -0,50% | 1,01% | 36.255 |
| 08/08/1997 | 47,26 | 47,72 | 46,79 | 46,79 | -2,91% | 1,98% | 40.315 |
| 07/08/1997 | 48,42 | 48,42 | 47,72 | 48,19 | -0,48% | 1,45% | 24.285 |
| 06/08/1997 | 48,19 | 48,66 | 47,96 | 48,42 | +0,49% | 1,46% | 24.686 |
| 05/08/1997 | 48,19 | 48,19 | 47,26 | 48,19 | +1,98% | 1,94% | 40.369 |
| 04/08/1997 | 47,96 | 48,19 | 46,32 | 47,26 | -0,98% | 3,90% | 24.472 |
| 01/08/1997 | 47,26 | 47,96 | 46,09 | 47,72 | +0,00% | 3,96% | 26.450 |
| 31/07/1997 | 50,06 | 50,06 | 47,26 | 47,72 | -3,77% | 5,61% | 57.147 |
| 30/07/1997 | 49,13 | 49,59 | 48,66 | 49,59 | +1,44% | 1,90% | 32.835 |
| 29/07/1997 | 48,19 | 50,06 | 47,72 | 48,89 | +1,95% | 4,85% | 62.784 |
| 28/07/1997 | 46,09 | 47,96 | 45,85 | 47,96 | +4,06% | 4,57% | 63.666 |
| 25/07/1997 | 45,15 | 46,09 | 45,15 | 46,09 | +1,55% | 2,07% | 61.716 |
| 24/07/1997 | 45,85 | 45,85 | 44,92 | 45,38 | -1,02% | 2,04% | 81.700 |
| 23/07/1997 | 45,15 | 45,85 | 44,92 | 45,85 | +2,08% | 2,07% | 93.081 |
| 22/07/1997 | 44,45 | 45,15 | 44,45 | 44,92 | +1,05% | 1,58% | 72.616 |
| 21/07/1997 | 46,55 | 46,55 | 44,45 | 44,45 | -4,52% | 4,52% | 85.093 |
| 18/07/1997 | 46,32 | 46,79 | 46,32 | 46,55 | +0,50% | 1,01% | 54.449 |
| 17/07/1997 | 45,85 | 46,79 | 45,85 | 46,32 | +0,51% | 2,04% | 95.833 |
| 16/07/1997 | 46,79 | 47,26 | 45,85 | 46,09 | -2,48% | 3,00% | 76.463 |
| 15/07/1997 | 48,19 | 48,66 | 46,79 | 47,26 | -1,94% | 3,88% | 112.317 |
| 14/07/1997 | 47,96 | 48,66 | 47,02 | 48,19 | -0,48% | 3,41% | 25.221 |
| 11/07/1997 | 48,66 | 49,13 | 48,19 | 48,42 | -1,43% | 1,92% | 18.247 |
| 10/07/1997 | 49,59 | 49,59 | 48,66 | 49,13 | -0,94% | 1,89% | 11.515 |
| 09/07/1997 | 48,19 | 49,59 | 47,72 | 49,59 | +4,95% | 3,88% | 133.610 |
| 08/07/1997 | 48,66 | 49,36 | 47,26 | 47,26 | -4,27% | 4,33% | 18.060 |